Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 41

    1.

    Obesity is not protective against fracture in postmenopausal women: GLOW.

    Compston JE, Watts NB, Chapurlat R, Cooper C, Boonen S, Greenspan S, Pfeilschifter J, Silverman S, Díez-Pérez A, Lindsay R, Saag KG, Netelenbos JC, Gehlbach S, Hooven FH, Flahive J, Adachi JD, Rossini M, Lacroix AZ, Roux C, Sambrook PN, Siris ES; Glow Investigators.

    Am J Med. 2011 Nov;124(11):1043-50.

    PMID:
    22017783
    [PubMed - indexed for MEDLINE]
    2.

    Cementless revision TKA with bone grafting of osseous defects restores bone stock with a low revision rate at 4 to 10 years.

    Hanna SA, Aston WJ, de Roeck NJ, Gough-Palmer A, Powles DP.

    Clin Orthop Relat Res. 2011 Nov;469(11):3164-71. Epub 2011 Jun 16.

    PMID:
    21678098
    [PubMed - indexed for MEDLINE]
    3.

    How much vitamin D do we need for skeletal health?

    von Domarus C, Brown J, Barvencik F, Amling M, Pogoda P.

    Clin Orthop Relat Res. 2011 Nov;469(11):3127-33.

    PMID:
    21448774
    [PubMed - indexed for MEDLINE]
    4.

    Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis.

    Ascenzi MG, Liao VP, Lee BM, Billi F, Zhou H, Lindsay R, Cosman F, Nieves J, Bilezikian JP, Dempster DW.

    J Bone Miner Res. 2012 Mar;27(3):702-12.

    PMID:
    22161803
    [PubMed - in process]
    5.

    The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT).

    Black DM, Reid IR, Boonen S, Bucci-Rechtweg C, Cauley JA, Cosman F, Cummings SR, Hue TF, Lippuner K, Lakatos P, Leung PC, Man Z, Martinez RL, Tan M, Ruzycky ME, Su G, Eastell R.

    J Bone Miner Res. 2012 Feb;27(2):243-54.

    PMID:
    22161728
    [PubMed - in process]
    6.

    LRP5, serotonin, and bone: complexity, contradictions, and conundrums.

    Goltzman D.

    J Bone Miner Res. 2011 Sep;26(9):1997-2001. doi: 10.1002/jbmr.462. No abstract available.

    PMID:
    21713997
    [PubMed - indexed for MEDLINE]
    7.

    Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study.

    Kim SY, Schneeweiss S, Liu J, Solomon DH.

    J Bone Miner Res. 2012 Apr;27(4):789-96. doi: 10.1002/jbmr.1489.

    PMID:
    22162140
    [PubMed - in process]
    8.

    A population-based study examining calcaneus quantitative ultrasound and its optimal cut-points to discriminate osteoporotic fractures among 9352 Chinese women and men.

    Liu JM, Ma LY, Bi YF, Xu Y, Huang Y, Xu M, Zhao HY, Sun LH, Tao B, Li XY, Wang WQ, Ning G.

    J Clin Endocrinol Metab. 2012 Mar;97(3):800-9. Epub 2011 Dec 14.

    PMID:
    22170722
    [PubMed - in process]
    9.

    Type of dietary fat is associated with the 25-hydroxyvitamin D3 increment in response to vitamin D supplementation.

    Niramitmahapanya S, Harris SS, Dawson-Hughes B.

    J Clin Endocrinol Metab. 2011 Oct;96(10):3170-4. Epub 2011 Aug 3.

    PMID:
    21816779
    [PubMed - indexed for MEDLINE]
    10.

    Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome.

    Freriks K, Timmermans J, Beerendonk CC, Verhaak CM, Netea-Maier RT, Otten BJ, Braat DD, Smeets DF, Kunst DH, Hermus AR, Timmers HJ.

    J Clin Endocrinol Metab. 2011 Sep;96(9):E1517-26. Epub 2011 Jul 13.

    PMID:
    21752892
    [PubMed - indexed for MEDLINE]
    11.

    Stable bone density in HAART-treated individuals with HIV: a meta-analysis.

    Bolland MJ, Wang TK, Grey A, Gamble GD, Reid IR.

    J Clin Endocrinol Metab. 2011 Sep;96(9):2721-31. Epub 2011 Jun 29.

    PMID:
    21715534
    [PubMed - indexed for MEDLINE]
    12.

    Performance of risk indices for identifying low bone mineral density and osteoporosis in Mexican Mestizo women with rheumatoid arthritis.

    Gonzalez-Lopez L, Gamez-Nava JI, Vega-Lopez A, Rodriguez-Jimenez NA, Gonzalez-Montoya N, Aguilar-Chavez E, Alcaraz-Lopez MF, Rocha-Muñoz AD, Castro-Lizano N, Morales-Romero J, Salazar-Paramo M, Suarez-Almazor ME.

    J Rheumatol. 2012 Feb;39(2):247-53. Epub 2011 Dec 15.

    PMID:
    22174197
    [PubMed - in process]
    13.

    Effect of zoledronic acid compared with raloxifene on bone turnover markers in postmenopausal women with low bone density.

    Bachmann G, Kriegman A, Gonçalves J, Kianifard F, Warren M, Simon JA.

    Menopause. 2011 Aug;18(8):851-6.

    PMID:
    21796066
    [PubMed - indexed for MEDLINE]
    14.

    Bone health medications: research questions versus clinical choices.

    Goldstein SR.

    Menopause. 2011 Aug;18(8):835-6. No abstract available.

    PMID:
    21785375
    [PubMed - indexed for MEDLINE]
    15.

    Genistein, a phytoestrogen, improves total cholesterol, and Synergy, a prebiotic, improves calcium utilization, but there were no synergistic effects.

    Legette LL, Lee WH, Martin BR, Story JA, Arabshahi A, Barnes S, Weaver CM.

    Menopause. 2011 Aug;18(8):923-31.

    PMID:
    21659907
    [PubMed - indexed for MEDLINE]
    16.

    The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.

    Hadji P, Zanchetta JR, Russo L, Recknor CP, Saag KG, McKiernan FE, Silverman SL, Alam J, Burge RT, Krege JH, Lakshmanan MC, Masica DN, Mitlak BH, Stock JL.

    Osteoporos Int. 2011 Dec 13. [Epub ahead of print]

    PMID:
    22159672
    [PubMed - as supplied by publisher]
    17.

    Prevention of disuse osteoporosis in rats by Cordyceps sinensis extract.

    Qi W, Yan YB, Lei W, Wu ZX, Zhang Y, Liu D, Shi L, Cao PC, Liu N.

    Osteoporos Int. 2011 Dec 13. [Epub ahead of print]

    PMID:
    22159671
    [PubMed - as supplied by publisher]
    18.

    Differential responsiveness to 17β-estradiol of mesenchymal stem cells from postmenopausal women between osteoporosis and osteoarthritis.

    Jin WJ, Jiang SD, Jiang LS, Dai LY.

    Osteoporos Int. 2011 Dec 10. [Epub ahead of print]

    PMID:
    22159632
    [PubMed - as supplied by publisher]
    19.

    Relationship between serum RANKL and RANKL in bone.

    Findlay DM, Atkins GJ.

    Osteoporos Int. 2011 Oct;22(10):2597-602. Epub 2011 Aug 18. Review.

    PMID:
    21850548
    [PubMed - indexed for MEDLINE]
    20.

    Coordinator-based systems for secondary prevention in fragility fracture patients.

    Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML, McLellan AR, Mitchell PJ, Sale JE, Wahl DA; IOF CSA Fracture Working Group.

    Osteoporos Int. 2011 Jul;22(7):2051-65. Epub 2011 May 24. Review.

    PMID:
    21607807
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk